BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32278147)

  • 1. Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS.
    Liang K
    Infect Genet Evol; 2020 Aug; 82():104306. PubMed ID: 32278147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.
    Hon KL; Leung KKY; Leung AKC; Sridhar S; Qian S; Lee SL; Colin AA
    Pediatr Pulmonol; 2020 Jul; 55(7):1584-1591. PubMed ID: 32483934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reproductive number of COVID-19 is higher compared to SARS coronavirus.
    Liu Y; Gayle AA; Wilder-Smith A; Rocklöv J
    J Travel Med; 2020 Mar; 27(2):. PubMed ID: 32052846
    [No Abstract]   [Full Text] [Related]  

  • 6. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
    Li YC; Bai WZ; Hashikawa T
    J Med Virol; 2020 Jun; 92(6):552-555. PubMed ID: 32104915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.
    Rokni M; Ghasemi V; Tavakoli Z
    Rev Med Virol; 2020 May; 30(3):e2107. PubMed ID: 32267987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doubling Time of the COVID-19 Epidemic by Province, China.
    Muniz-Rodriguez K; Chowell G; Cheung CH; Jia D; Lai PY; Lee Y; Liu M; Ofori SK; Roosa KM; Simonsen L; Viboud C; Fung IC
    Emerg Infect Dis; 2020 Aug; 26(8):1912-1914. PubMed ID: 32330410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.
    Wang Y; Wang Y; Chen Y; Qin Q
    J Med Virol; 2020 Jun; 92(6):568-576. PubMed ID: 32134116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The within-host viral kinetics of SARS-CoV-2.
    Li CT; Xu JH; Liu JW; Zhou YC
    Math Biosci Eng; 2020 Mar; 17(4):2853-2861. PubMed ID: 32987502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century.
    da Costa VG; Moreli ML; Saivish MV
    Arch Virol; 2020 Jul; 165(7):1517-1526. PubMed ID: 32322993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
    Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
    Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparing for emerging respiratory pathogens such as SARS-CoV, MERS-CoV, and SARS-CoV-2.
    Al-Tawfiq JA; Garout MA; Gautret P
    Infez Med; 2020 Jun; 28(suppl 1):64-70. PubMed ID: 32532941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
    Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
    J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
    Peeri NC; Shrestha N; Rahman MS; Zaki R; Tan Z; Bibi S; Baghbanzadeh M; Aghamohammadi N; Zhang W; Haque U
    Int J Epidemiol; 2020 Jun; 49(3):717-726. PubMed ID: 32086938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience.
    Algaissi AA; Alharbi NK; Hassanain M; Hashem AM
    J Infect Public Health; 2020 Jun; 13(6):834-838. PubMed ID: 32451260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak.
    Zhao S; Lin Q; Ran J; Musa SS; Yang G; Wang W; Lou Y; Gao D; Yang L; He D; Wang MH
    Int J Infect Dis; 2020 Mar; 92():214-217. PubMed ID: 32007643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus Disease 2019: Coronaviruses and Blood Safety.
    Chang L; Yan Y; Wang L
    Transfus Med Rev; 2020 Apr; 34(2):75-80. PubMed ID: 32107119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19, SARS and MERS: are they closely related?
    Petrosillo N; Viceconte G; Ergonul O; Ippolito G; Petersen E
    Clin Microbiol Infect; 2020 Jun; 26(6):729-734. PubMed ID: 32234451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.